SCHEMBL6174499

SCHEMBL6174499

CCCCOC(=O)Nc1cnccc1C(C)C1(C(C)c2ccncc2NC(=O)OCCCC)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 2/20 0.35
RXFP1 Q9HBX9 3/20 0.35
NAMPT P43490 1/20 0.34
THRB P10828 1/20 0.33
PKM P14618 2/20 0.33
KMT2A Q03164 3/20 0.33
GLA P06280 1/20 0.33
SPHK1 Q9NYA1 1/20 0.32
MAPT P10636 3/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
ALOX12 P18054 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174137 0.88 CYP2C9 (0.36) GAACYP2C9CYP3A4CYP2C19ALDH1A1
SCHEMBL6171796 0.87 IGF1R (0.36) GAACYP2C9CYP3A4CYP2C19ALDH1A1
SCHEMBL6173613 0.85 KIF11 (0.37) GAACYP2C9CYP3A4CYP2C19ALDH1A1
SCHEMBL6175647 0.85 ALDH1A1 (0.38) GAACYP2C9CYP3A4CYP2C19ALDH1A1
SCHEMBL6175557 0.83 GAA (0.36) GAACYP2C9CYP3A4CYP2C19ALDH1A1
SCHEMBL6170996 0.83 CYP3A4 (0.50) GAACYP2C9CYP3A4CYP2C19ALDH1A1
SCHEMBL6173386 0.82 ALDH1A1 (0.41) GAACYP2C9CYP3A4CYP2C19ALDH1A1
SCHEMBL6175558 0.82 RXFP1 (0.35) GAACYP2C19ALDH1A1RXFP1NAMPT
SCHEMBL6172506 0.82 NAMPT (0.40) GAACYP2C9CYP3A4CYP2C19ALDH1A1
SCHEMBL6171051 0.82 NAMPT (0.48) CYP2C9NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed